Multi Radiance Medical Gets FDA Clearance for MRM FibroLux Laser

October 6, 2022

Ohio-based Multi Radiance Medical has received FDA clearance for its MRM FibroLux laser therapy to treat pain associated with fibromyalgia, a condition that includes widespread musculoskeletal pain.

The laser is designed to deliver optimal doses of light energy using a combination of wavelengths administered at the correct power, duration and frequency of application. The treatments last an average of three to six minutes.

The device is being promoted as a nonpharmacological, noninvasive and side effect-free treatment. Fibromyalgia is usually treated with prescription medications, but the drugs only provide relief for a minority of patients.

A patent is pending for the laser therapy.

View today's stories